Association of MTHFR, MTR, MTRR, RFC1, and DHFR gene polymorphisms with susceptibility to sporadic colon cancer

DNA and Cell Biology

Volumn 30, Issue 10, 2011, Pages 771-776

  Jokić, Mladen ^a   Brčić Kostić, Krunoslav ^a   Stefulj, Jasminka ^a   Ivković, Tina Catela ^a   Božo, Lončar ^b   Gamulin, Marija ^c   Kapitanović, Sanja ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b University of Zagreb School of Medicine   (Croatia)

^c KBC Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; METHIONINE SYNTHASE; METHIONINE SYNTHASE REDUCTASE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); REDUCED FOLATE CARRIER;

ARTICLE; CANCER SUSCEPTIBILITY; COLON CANCER; CONTROLLED STUDY; CROATIA; DNA POLYMORPHISM; FEMALE; FOLATE METABOLISM; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; CROATIA; DNA FINGERPRINTING; FEMALE; FERREDOXIN-NADP REDUCTASE; FOLIC ACID; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MEMBRANE TRANSPORT PROTEINS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; RISK FACTORS; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 80053584694     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2010.1189     Document Type: Article

References (35)

1. Adams, M., Lucock, M., Stuart, J., Fardell, S., Baker, K., and Ng, X. (2007). Preliminary evidence for involvement of the folate gene polymorphism 19 bp deletion-DHFR in occurrence of autism. Neurosci Lett 422, 24-29. (Pubitemid 47086296)
2. Ahmed, F.E. (2006). Gene-gene, gene-environment & multiple interactions in colorectal cancer. J Environ Sci Health Part C 24, 1-101.
3. Brown, C.A., McKinney, K.Q., Kaufman, J.S., Gravel, R.A., and Rozen, R. (2000). A common polymorphism in methioninesynthase reductase increases risk of premature coronary artery disease. J Cardiovasc Risk 7, 197-200. (Pubitemid 30463749)
4. Chen, J., Giovannucci, E., Hankinson, S.E., Ma, J., Willett,W.C., et al. (1998). A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms and risk of colorectal adenoma. Carcinogenesis 19, 2129-2132. (Pubitemid 29010251)
5. Chen, J., Ma, J., Stampfer, M.J., Palomeque, C., Selhub, J., and Hunter, D.J. (2002). Linkage disequilibrium between the 677C>T and 1298A>C polymorphisms in human methylenetetrahydrofolate reductase gene and their contributions to risk of colorectal cancer. Pharmacogenetics 12, 339-342. (Pubitemid 34620663)
6. Curtin, K., Bigler, J., Slattery, M.L., Caan, B., Potter, J.D., and Ulrich, C.M. (2004). MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol Biomark Prev 13, 285-292. (Pubitemid 38222562)
7. De Marco, P., Calevo, M.G., Moroni, A., Arata, L., Merello, E., Cama, A., et al. (2001). Polymorphism in genes involved in folate metabolism as risk factors for NTDs. Eur J Pediatr Surg 11(suppl 1), S14-S17.
8. Eussen, S.J.P.M., Vollset, S.E., Igland, J., Meyer, K., Fredriksen, Å., Ueland, P.M., et al. (2010). Plasma folate, related genetic variants and colorectal cancer risk in EPIC. Cancer Epidemiol Biomark Prev 19, 1328-1340.
9. Frosst, P., Blom, H.J., Milos, R., Goyette, P., Sheppard, C.A., and Matthews, R.G. (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10, 111-113.
10. Haghighi, M.M., Radpour, R., Mahmoudi, T., Mohebbi, S.R., Vahedi, M., and Zali, M.R. (2009). Association between MTHFR polymorphism (C677T) with nonfamilial colorectal cancer. Oncol Res 18, 57-63.
11. Harmon, D.L., Shields, D.C., Woodside, J.V., McMaster, D., Yarnell, J.W., Young, I.S., et al. (1999). Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 17, 298-309. (Pubitemid 29522203)
12. Hill, W.G. (1974). Estimation of linkage disequilibrium in randomly mating populations. Heredity 33, 229-239.
13. Huang, Y., Han, S., Li, Y., Mao, Y., and Xie, Y. (2007). Different roles of MTHFR C677T and A1298C polymorphisms in colorectal adenoma and colorectal cancer: a meta-analysis. J Hum Genet 52, 73-85. (Pubitemid 46020567)
14. Hubner, R.A., and Houlston, R.S. (2007). MTHFR C677T and colorectal cancer risk: a meta-analysis of 25 populations. Int J Cancer 120, 1027-1035. (Pubitemid 46214302)
15. Johnson, W.G., Stenroos, E.S., Spychala, J.R., Chathupt, S., Ming, S.X., and Buyske, S. (2004). New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy? Am J Med Genet 124A, 339-345. (Pubitemid 38141374)
16. Keku, T., Millikan, R., Worley, K., Winkel, S., Eaton, A., Biscocho, L., et al. (2002). 5,10- Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiol Biomark Prev 11, 1611-1621. (Pubitemid 36020015)
17. Komló si, V., Hitre, E., Pap, É ., Adleff, V., Réti, A., Székely, É ., Bíro, A., Rudnai, P., Schoket, B., Mü ller, J., Tó th, B., Ottó , S., Ká sler, M., Kralovánszky, J., and Budai, B. (2010). SHMT1 1420 and MTHFR 677 variants are associated with renal but not colon cancer. BMC Cancer 10, 525.
18. Kwak, S.Y., Kim, U.K., Cho, H.J., Lee, H.K., Kim, H.J., Kin, N.K., and Hwang, S.G. (2008). Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population. Anticancer Res 28, 2807-2011.
19. Leclerc, D., Wilson, A., Dumas, R., Gafuik, C., Song, D., Watkins, D., et al. (1998). Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci USA 95, 3059-3064. (Pubitemid 28135854)
20. Little, J., Sharp, L., Duthie, S., and Narayanan, S. (2003). Colon cancer and genetic variation in folate metabolism: the clinical bottom line. J Nutr 133, 3758S-3766S. (Pubitemid 37392597)
21. Ma, J., Stampfer, M.J., Christensen, B., Giovannucci, E., Hunter, D.J., Chen, J., et al. (1999). A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine and colorectal cancer risk. Cancer Epidemiol Biomark Prev 8, 825-829. (Pubitemid 29445020)
22. Ma, J., Stampfer, M.J., Giovannucci, E., Artigas, C., Hunter, D.J., Fuchs, C., et al. (1997). Methylenetetrahydrofolate reductase polymorphism, dietary interactions and risk of colorectal cancer. Cancer Res 57, 1098-1102. (Pubitemid 27138608)
23. Matsuo, K., Hamajima, N., Hirai, T., Kato, T., Inoue, M., Takezaki, T., et al. (2002). Methionine synthase reductase gene A66G polymorphism is associated with rik of colorectal cancer. Asian Pac J Cancer Prev 3, 353-359.
24. Sachse, C., Smith, G., Wilkie, M.J.V., Barrett, J.H., Waxman, R., Sullivan, F., et al. (2002). A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 23, 1839-1849. (Pubitemid 35363272)
25. Schneider, S., Roessli, D., and Excoffier, L. (2000). Arlequin: a software for population genetics data analysis, Ver 2.000. Genetics and Biometry Lab, Department of Antropology, University of Geneva, Geneva, Switzerland.
26. Shannon, B., Gnanasampanthan, S., Beilby, J., and Iacopetta, B. (2002). A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability. Gut 50, 520-524. (Pubitemid 34638872)
27. Slattery, M.L., Potter, J.D., Samowitz, W., Schaffer, D., and Leppert, M. (1999). Methylenetetrahydrofolate reductase, diet and risk of colon cancer. Cancer Epidemiol Biomark Prev 8, 513-518. (Pubitemid 29270335)
28. Spaventi, R., Pecur, L., Pavelic, K., Pavelic, Z.P., Spaventi, S., and Stambrook, P.J. (1994). Human tumour bank in Croatia: a possible model for a small bank as a part of future European tumour bank network. Eur J Cancer 30A, 419.
29. Steck, S.E., Keku, T., Butler, L.M., Galanko, J., Massa, B., Millikan, R.C., and Sandler, R.S. (2008). Polymorphisms in methionine synthase, methionine synthase reductase and serine hydroxymethyltransferase, folate and alcohol intake, and colon cancer risk. J Nutrigenet Nutrigenomics 1, 196-204. (Pubitemid 351873358)
30. Stempak, J.M., Sohn, K.J., Chiang, E.P., Shane, B., and Kim, Y.I. (2005). Cell and stage of transformation-specific effects of folate deficiency on methionine cycle intermediates and DNA methylation in an in vitro model. Carcinogenesis 26, 981-990. (Pubitemid 41214328)
31. Ulrich, C.M. (2005a). Nutrigenetics in cancer research-folate metabolism and colorectal cancer. J Nutr 135, 2698-2702. (Pubitemid 43156616)
32. Ulrich, C.M., Curtin, K., Potter, J.D., Bigler, J., Caan, B., and Slattery, M.L. (2005b). Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Biomark Prev 14, 2509-2516. (Pubitemid 41752708)
33. Wilson, A., Platt, R., Wu, Q., Leclerc, D., Christensen, B., Yang, H., et al. (1999). A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab 67, 317-323. (Pubitemid 29406795)
34. Winkelmayer, W.C., Eberle, C., Sunder-Plassmann, G., and Fö - dinger, M. (2003). Effects of the glutamate caboxypeptidease II (GCP2 1561C>T) and reduced folate carrier (RFC1 80G>A) allelic variants on folate and total homocysteine levels in kidney transplant patients. Kidney Int 63, 2280-2285. (Pubitemid 36605843)
35. Yu, K., Zhang, J., Zhang, J., Dou, C., Gu, S., Xie, Y., Mao, Y., and Ji, C. (2010). Methionine synthase A2756G polymorphism and cancer risk: a meta-analysis. Eur J Hum Genet 18, 370-378.